Search the Newsreel

Analysts Offer Insights on Energy Companies: Crescent Energy Company Class A (CRGY), Chevron (CVX) and Williams Co (WMB)

Three analysts from Siebert Williams Shank & Co, Piper Sandler, and Stifel Nicolaus have issued bullish ratings for Crescent Energy Company Class A (CRGY), Chevron (CVX), and Williams Co (WMB) respectively. Each company received a Buy rating with specific price targets, suggesting significant upside …

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN) and Crescent Biopharma (CBIO)

Analysts from Stifel Nicolaus have issued bullish sentiments on Dyne Therapeutics (DYN) and Crescent Biopharma (CBIO). Dyne Therapeutics received a Buy rating with a $37.00 price target, and Crescent Biopharma also received a Buy rating with a $28.00 price target, both indicating significant upside …

Crescent Energy Q2 Earnings Call Centers on Permian Synergy Expansion

Crescent Energy Company CRGY centered its second-quarter 2026 earnings call on higher production, lower costs and sharply expanded Permian synergies without a higher development budget. Management also tied stronger free cash flow to faster deleveraging. Attention now shifts to how quickly the savings reach …

Mountain Crest Acquisition 6 Corp. Revenue Breakdown – NASDAQ:MCAHU

This article provides a basic overview of Mountain Crest Acquisition 6 Corp. (NASDAQ: MCAHU) on TradingView. It primarily lists sections available on the platform for the company, such as Financials, Community, and Technicals, but does not present any actual revenue breakdown or detailed financial …

ACRES Commercial Realty (ACR) Stock Book Value Slides As Losses Deepen

Crescent Energy (CRGY) Stock Shrugs Off Profit Surge And Cash Flow Strength

Crescent Energy boosts guidance and strengthens balance sheet

Crescent Energy (CRGY) announced record operating cash flow of $707 million and levered free cash flow of $418 million in Q2 2026, leading to increased production guidance and a strengthened balance sheet. The company also expanded its Permian synergy target and reiterated its capital …

Crescent Energy Co (CRGY) (Q2 2026) Earnings Call Highlights: Record Production and Synergy ...

This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record quarterly production of 335,000 boe/d and 140,000 bbl/d of oil, exceeding guidance. Record levered …

Crescent Energy (CRGY) Earnings Beat Puts Its Valuation Story Back In Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Crescent Energy (CRGY) has caught investor attention after reporting second quarter 2026 results that surpassed Wall Street expectations on both revenue and earnings, supported …

Crescent Energy (NYSE:CRGY) Stock Price Expected to Rise, Mizuho Analyst Says

Crescent Energy Bumps Up Production Forecast

Crescent Energy Bumps Up Production Forecast·rigzone.com This article was first published on Rigzone here Crescent Energy Co now expects its full-year production to range from 327,000 barrels of oil equivalent a day (boed) to 335,000 boed, of which 40-42 percent would be oil. That …

ACRES Commercial Realty to Internalize Manager, Issue 7.48M Shares and Price $200M 8.625% Notes

ACRES Commercial Realty plans to internalize its manager, ACRES Capital, through a merger expected to close on August 6, 2026. This involves issuing approximately 7.48 million shares and assuming about $185 million of ACC debt. Additionally, the company will conduct a private placement of …

Crescent Energy Co (CRGY) faces results after a sharp four-week repair

The oil-and-gas producer reports with medium-term performance still below water, leaving the weekly setup short of a clean recovery.

Crescent Energy Reports Second Quarter 2026 Results

Crescent Energy Company announced its financial and operating results for the second quarter of 2026. The company's earnings release and supplemental presentation are available on its website, and a conference call is scheduled for August 4, 2026, to discuss these results. Crescent Energy is …

Form 4 Acres Commercial Realty Corp For: 3 August By Investing.com

This article announces the filing of Form 4 by Acres Commercial Realty Corp for August 3rd, indicating insider trading activity. It provides details of the event and links to related financial markets data and news. The content focuses on financial reporting and is typical …

ACRES Commercial Realty (NYSE: ACR) notes Eagle Point funds’ sale of Series D preferred

Entities affiliated with Eagle Point Credit Management LLC and Eagle Point DIF GP I LLC, acting as 10% owners of ACRES Commercial Realty Corp. (NYSE: ACR), reported open-market sales of 992 shares of 7.875% Series D Preferred Stock at $21.80 per share on July …

Crescent Energy (CRGY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Crescent Energy (CRGY) reported $1.39 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 55.3%. EPS of $0.69 for the same period compares to $0.43 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.23 …

Crescent Energy (CRGY) Surpasses Q2 Earnings and Revenue Estimates

Crescent Energy (CRGY) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Crescent Energy (NYSE:CRGY) Surprises With Strong Q2 CY2026

Crescent Energy (NYSE:CRGY) Surprises With Strong Q2 CY2026 Oil and gas producer Crescent Energy (NYSE:CRGY) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 55.3% year on year to $1.39 billion. Its non-GAAP profit of $0.69 per share was 16.5% …

Crescent Capital BDC (CCAP) Expected to Release Quarterly Earnings on Monday

Crescent Capital BDC (CCAP) is scheduled to release its Q2 2026 earnings after market close on Monday, August 10th, with analysts projecting earnings of $0.37 per share and revenue of $37.1 million. In the previous quarter, the company surpassed earnings estimates but missed revenue …

CRESCENT BIOPHARMA, INC. SEC Filing (Aug 3, 2026)

This article details an SEC filing by CRESCENT BIOPHARMA, INC. (CBIO) on August 3, 2026, which is a Notice of Effectiveness for a POS AM submission. The filing indicates an effectiveness date of July 31, 2026, and provides key company and filing identification numbers. …

Crescent Biopharma Announces Grants of Inducement Awards

Crescent Biopharma announced that its Board's Compensation Committee approved the grant of options to purchase 19,425 shares to a non-executive employee as an inducement award. These options were granted on July 31, 2026, with a 10-year term and an exercise price of $14.47, vesting …

Insider Selling: ACRES Commercial Realty (NYSE:ACR) Major Shareholder Sells $19,794.40 in Stock

Crescent Energy (NYSE:CRGY) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Crescent expects trial data in 2027 after $143.7M offering

Crescent Biopharma reported a Q2 2026 net loss of $24.8 million but extended its cash runway into the second half of 2028 after a $143.7 million public offering in July 2026. The company anticipates multiple key clinical data readouts across its oncology pipeline in …

CBIO: Cash runway extended to 2028 as global oncology trials progress toward key 2027 data

Crescent Biopharma (CBIO) has extended its cash runway into the second half of 2028 following a $143.7 million public offering. The company is advancing enrollment in multiple global oncology trials, with key data readouts anticipated in 2027. R&D expenses have increased to support the …

CBIO Q2'26 Earnings: EPS estimate is (0.74) USD

Crescent Biopharma, Inc. (CBIO) is scheduled to release its Q2'26 earnings on July 30, with an estimated revenue of $357.14 thousand and an anticipated EPS of ($0.74). The article provides a table of historical and estimated revenue and EPS figures, along with surprise percentages …

CRESCENT BIOPHARMA, INC. 2026: Revenue $0 Net income ($24.84M), EPS ($0.74) — 10-Q Summary

Crescent Biopharma, Inc. (CBIO) reported a net loss of ($24.84M) for the 2026 quarter with no revenue, an increase from ($21.79M) in the prior-year quarter. Diluted loss per share improved significantly to ($0.74) from ($4.93) a year earlier, representing an 85% change. The company …

Silvercrest Asset Management Group (NASDAQ:SAMG) Upgraded by Wall Street Zen to Hold Rating

Silvercrest Asset Management Group Inc. Q2 2026 Earnings Call Summary

Crescent Biopharma (CBIO) Gets a Buy from Wedbush

CS40X Bond Profile — Key Metrics

This article provides a bond profile for CS40X, issued by Cresud S.A., detailing key metrics such as issue date, maturity date, face value, minimum denomination, and coupon rate. It also describes Cresud S.A.'s business operations, which include agricultural activities and urban property/investment segments in …

Silvercrest Asset Management Group Inc. 2026 Q2 10-Q Report: Financial Highlights, Risk Factors, and Key Disclosures

Silvercrest Asset Management Group Inc. has released its Q2 2026 report, highlighting a significant decrease in cash and cash equivalents from $44.1 million to $20.7 million, alongside an increase in equity method investments. The company maintains compliance with regulatory requirements and is classified as …

Enterprise value to revenue forward of Oasis Crescent Property Fund – JSE:OAS

Short Interest in Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) Decreases By 35.3%

Short interest in Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) significantly decreased by 35.3% in July, totaling 385,359 shares by July 15th, representing about 1.0% of its outstanding shares. The stock traded down 3.5% to $11.20, despite the company reporting $0.45 EPS on $182.78 million in …

FutureCrest Acquisition Ord Shs Class A (FCRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

This article from TradingKey reports on FutureCrest Acquisition Ord Shs Class A (FCRS) and its revenue breakdown. It states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page provides basic stock information …